• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Zoom’s stock drop likely nixed Five9 deal, say analysts

October 1, 2021 by David Barret Leave a Comment

October 1, 2021

By Aniruddha Ghosh

(Reuters) – A slump in Zoom Video Communications Inc’s share price likely limited its ability to sweeten a nearly $15 billion all-stock offer for call center software firm Five9 and led to the deal’s collapse, Wall Street analysts said on Friday.

Five9 shareholders on Thursday voted down the sale to Zoom, denting the company’s efforts to diversify its offerings as growth slows in its virtual conferencing business after a boom during the pandemic.

While some analysts expected Zoom to raise its offer to address Five9 shareholder worries about the price, others said an almost 30% drop in Zoom shares since July on the back of slowing growth only dampened the prospects.

Under the deal terms, Five9 shareholders would have received 0.5533 Zoom share for each share held. The terms then implied a 12.8% premium over Five9’s market price.

“The deal was negatively perceived from the beginning given the small premium and all-stock structure,” Jefferies analyst Samad Samana said in a note to clients. “ZM’s stock declining 28% since the announcement only compounded the issues and likely made revising the terms difficult as well.”

The deal – which would have been Zoom’s biggest-ever purchase if completed – was also opposed by shareholder proxy advisory firms ISS and Glass Lewis. The firms had recommended that Five9 shareholders vote against the deal, citing growth concerns and dual-class shares.

“While we think the deal made strategic sense for both companies over the long term, the variable deal tied to volatile (Zoom) shares was not an economically attractive deal for (Five9) shareholders at this time,” Piper Sandler analysts said.

Analysts at Barclays blamed the fall in Zoom’s share price and possible regulatory scrutiny for the deal falling through.

A U.S. Justice Department panel had been reviewing the deal over possible national security concerns, though analysts had said it was unlikely the deal would be scrapped as a result.

“(Our) conversations, especially with event-driven investors, suggest that they believe Five9 was important enough to Zoom that they would ultimately bump/sweeten the offer for Five9,” J.P. Morgan analysts said.

“Obviously, the recent pullback in stock prices for premium valuation software stocks makes the current situation all the more complicated.”

Zoom’s shares gained 1.6% to $265.79 in premarket trading, while Five9’s stock was down about 3% at $155.

(Reporting by Aniruddha Ghosh in Bengaluru; Editing by Sachin Ravikumar and Sriraj Kalluvila)

Source Link Zoom’s stock drop likely nixed Five9 deal, say analysts

David Barret
David Barret

Related posts:

  1. Australia central bank to stick with tapering plans, or maybe not
  2. Japan firms see economy recovering to pre-COVID level in FY2022
  3. Air New Zealand studying how to add low-emissions planes to fleet
  4. ECB’s Lagarde flags bottlenecks, energy and virus as key risks

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Lupus Linked To Virus That Over 95 Percent Of Us Carry – And Now We Finally Know How
  • This Whale’s Meal Plan? Over 70,000 Squid A Year, And It’ll Dive Incredible Depths To Get Them
  • There Are 23 Countries in North America: Do You Know Them All?
  • “Non-Gravitational Acceleration” Of Interstellar Object 3I/ATLAS Explained In New Study
  • Antiperspirant Before Bed, Or In The Morning? There Is A Right Answer
  • When Did Dogs Become Dogs? Familiar Forms Started To Arise Over 10,000 Years Ago
  • At 900 Meters Across, Earth’s Largest Modern Impact Crater Has Just Been Found By Scientists
  • The First Black Holes May Be From 1 Second After The Big Bang, Before Atoms Existed
  • “The Universe Will Just Get Colder And Deader From Now On” Major Euclid Survey Of The Cosmos Shows
  • Spiders Make “Scarecrows” Of Bigger Spiders Out Of Silk And Debris To Ward Off Predators
  • Having Sex Could Help Physical Injuries Heal Faster – But There’s A Catch
  • How To Win At Rock-Paper-Scissors: A Deep Dive Into Manual Warfare
  • Turns Out, The World’s Most Famous Star Cluster Is Just Part Of A Vast Family Of Stars
  • Watch First-Ever Video Footage Of A Humpback Whale Calf Nursing Underwater
  • People Are Blown Away Learning That You Can “Smell” Snow
  • New Bee Species With A Devilish Name Sports Horns On Its Head Like A Tiny Demon
  • The World’s Smallest Bear Isn’t Just A Guy In A Bear Suit, We Promise
  • Vowel Sounds “Thought To Be Unique To Humans” Discovered In Sperm Whales For The First Time
  • Bizarre Creature With “All-Body Brain” Challenges What We Know About Evolution of Nervous Systems
  • For First Time, Astronomers Record A Coronal Mass Ejection From A Star That’s Not Our Sun
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version